242 related articles for article (PubMed ID: 29154272)
1. Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer's Disease.
Gelman S; Palma J; Tombaugh G; Ghavami A
J Alzheimers Dis; 2018; 61(1):195-208. PubMed ID: 29154272
[TBL] [Abstract][Full Text] [Related]
2. Impairment of Spike-Timing-Dependent Plasticity at Schaffer Collateral-CA1 Synapses in Adult APP/PS1 Mice Depends on Proximity of Aβ Plaques.
Garad M; Edelmann E; Leßmann V
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573114
[TBL] [Abstract][Full Text] [Related]
3. Synaptic dysfunction in hippocampus of transgenic mouse models of Alzheimer's disease: a multi-electrode array study.
Chong SA; Benilova I; Shaban H; De Strooper B; Devijver H; Moechars D; Eberle W; Bartic C; Van Leuven F; Callewaert G
Neurobiol Dis; 2011 Dec; 44(3):284-91. PubMed ID: 21807097
[TBL] [Abstract][Full Text] [Related]
4. Synaptic fatigue is more pronounced in the APP/PS1 transgenic mouse model of Alzheimer's disease.
Zhang H; Gong B; Liu S; Fa' M; Ninan I; Staniszewski A; Arancio O
Curr Alzheimer Res; 2005 Apr; 2(2):137-40. PubMed ID: 15974910
[TBL] [Abstract][Full Text] [Related]
5. Age-related synaptic dysfunction in Tg2576 mice starts as a failure in early long-term potentiation which develops into a full abolishment of late long-term potentiation.
Fernández-Fernández D; Dorner-Ciossek C; Kroker KS; Rosenbrock H
J Neurosci Res; 2016 Mar; 94(3):266-81. PubMed ID: 26629777
[TBL] [Abstract][Full Text] [Related]
6. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
[TBL] [Abstract][Full Text] [Related]
7. Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein.
Fitzjohn SM; Morton RA; Kuenzi F; Rosahl TW; Shearman M; Lewis H; Smith D; Reynolds DS; Davies CH; Collingridge GL; Seabrook GR
J Neurosci; 2001 Jul; 21(13):4691-8. PubMed ID: 11425896
[TBL] [Abstract][Full Text] [Related]
8. Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1.
Parent A; Linden DJ; Sisodia SS; Borchelt DR
Neurobiol Dis; 1999 Feb; 6(1):56-62. PubMed ID: 10078973
[TBL] [Abstract][Full Text] [Related]
9. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
Zhao G; Liu HL; Zhang H; Tong XJ
Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
[TBL] [Abstract][Full Text] [Related]
10. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
[TBL] [Abstract][Full Text] [Related]
11. Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
Kartalou GI; Salgueiro-Pereira AR; Endres T; Lesnikova A; Casarotto P; Pousinha P; Delanoe K; Edelmann E; Castrén E; Gottmann K; Marie H; Lessmann V
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255764
[TBL] [Abstract][Full Text] [Related]
12. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease.
Stancu IC; Ris L; Vasconcelos B; Marinangeli C; Goeminne L; Laporte V; Haylani LE; Couturier J; Schakman O; Gailly P; Pierrot N; Kienlen-Campard P; Octave JN; Dewachter I
FASEB J; 2014 Jun; 28(6):2620-31. PubMed ID: 24604080
[TBL] [Abstract][Full Text] [Related]
13. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
Saul A; Sprenger F; Bayer TA; Wirths O
Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
[TBL] [Abstract][Full Text] [Related]
14. Impairment in hippocampal long-term potentiation in mice under-expressing the Alzheimer's disease related gene presenilin-1.
Morton RA; Kuenzi FM; Fitzjohn SM; Rosahl TW; Smith D; Zheng H; Shearman M; Collingridge GL; Seabrook GR
Neurosci Lett; 2002 Feb; 319(1):37-40. PubMed ID: 11814648
[TBL] [Abstract][Full Text] [Related]
15. Colivelin Ameliorates Impairments in Cognitive Behaviors and Synaptic Plasticity in APP/PS1 Transgenic Mice.
Wu M; Shi H; He Y; Yuan L; Qu X; Zhang J; Wang Z; Cai H; Qi J
J Alzheimers Dis; 2017; 59(3):1067-1078. PubMed ID: 28731445
[TBL] [Abstract][Full Text] [Related]
16. Age-dependent concomitant changes in synaptic dysfunction and GABAergic pathway in the APP/PS1 mouse model.
Oyelami T; Bondt A; den Wyngaert IV; Hoorde KV; Hoskens L; Shaban H; Kemp JA; Drinkenburg WH
Acta Neurobiol Exp (Wars); 2016; 76(4):282-293. PubMed ID: 28094819
[TBL] [Abstract][Full Text] [Related]
17. L-3-n-butylphthalide Rescues Hippocampal Synaptic Failure and Attenuates Neuropathology in Aged APP/PS1 Mouse Model of Alzheimer's Disease.
Zhang Y; Huang LJ; Shi S; Xu SF; Wang XL; Peng Y
CNS Neurosci Ther; 2016 Dec; 22(12):979-987. PubMed ID: 27439966
[TBL] [Abstract][Full Text] [Related]
18. Altered function of hippocampal CA1 pyramidal neurons in the rTg4510 mouse model of tauopathy.
Dalby NO; Volbracht C; Helboe L; Larsen PH; Jensen HS; Egebjerg J; Elvang AB
J Alzheimers Dis; 2014; 40(2):429-42. PubMed ID: 24448785
[TBL] [Abstract][Full Text] [Related]
19. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
Liu HL; Zhao G; Zhang H; Shi LD
Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
[TBL] [Abstract][Full Text] [Related]
20. Synaptic plasticity in the hippocampus of a APP/PS1 mouse model of Alzheimer's disease is impaired in old but not young mice.
Gengler S; Hamilton A; Hölscher C
PLoS One; 2010 Mar; 5(3):e9764. PubMed ID: 20339537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
